Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo
- PMID: 12874305
- PMCID: PMC166030
- DOI: 10.1128/IAI.71.8.4297-4303.2003
Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo
Abstract
Mycobacterium bovis is the causative agent of bovine tuberculosis (TB), and it has the potential to induce disease in humans. CD8(+) T cells (CD8 cells) have been shown to respond to mycobacterial antigens in humans, cattle, and mice. In mice, CD8 cells have been shown to play a role in protection against mycobacterial infection. To determine the role of CD8 cells in bovine TB in vivo, two groups of calves were infected with the virulent M. bovis strain AF2122/97. After infection, one group was injected with a CD8 cell-depleting monoclonal antibody (MAb), and the other group was injected with an isotype control MAb. Immune responses to mycobacterial antigens were measured weekly in vitro. After 8 weeks, the animals were killed, and postmortem examinations were carried out. In vitro proliferation responses were similar in both calf groups, but in vitro gamma interferon (IFN-gamma) production in 24-h whole-blood cultures was significantly higher in control cattle than in CD8 cell-depleted calves. Postmortem examination showed that calves in both groups had developed comparable TB lesions in the lower respiratory tract and associated lymph nodes. Head lymph node lesion scores, on the other hand, were higher in control calves than in CD8 cell-depleted calves. Furthermore, there was significant correlation between the level of IFN-gamma and the head lymph node lesion score. These experiments indicate that CD8 cells play a role in the immune response to M. bovis in cattle by contributing to the IFN-gamma response. However, CD8 cells may also play a deleterious role by contributing to the immunopathology of bovine TB.
Figures
Similar articles
-
Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.Tuberculosis (Edinb). 2013 May;93(3):363-72. doi: 10.1016/j.tube.2013.02.004. Epub 2013 Mar 19. Tuberculosis (Edinb). 2013. PMID: 23518075 Clinical Trial.
-
Lesions in cattle exposed to Mycobacterium bovis-inoculated calves.J Comp Pathol. 1999 Nov;121(4):321-37. doi: 10.1053/jcpa.1999.0330. J Comp Pathol. 1999. PMID: 10542122
-
A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.Infect Immun. 2003 Sep;71(9):4901-7. doi: 10.1128/IAI.71.9.4901-4907.2003. Infect Immun. 2003. PMID: 12933831 Free PMC article.
-
Effects of different tuberculin skin-testing regimens on gamma interferon and antibody responses in cattle experimentally infected with Mycobacterium bovis.Clin Vaccine Immunol. 2006 Mar;13(3):387-94. doi: 10.1128/CVI.13.3.387-394.2006. Clin Vaccine Immunol. 2006. PMID: 16522782 Free PMC article.
-
The role of gamma delta T cells in immunity to Mycobacterium bovis infection in cattle.Vet Immunol Immunopathol. 2014 Jun 15;159(3-4):133-43. doi: 10.1016/j.vetimm.2014.02.010. Epub 2014 Feb 24. Vet Immunol Immunopathol. 2014. PMID: 24636303 Review.
Cited by
-
Immune correlates of protection as a game changer in tuberculosis vaccine development.NPJ Vaccines. 2024 Oct 30;9(1):208. doi: 10.1038/s41541-024-01004-w. NPJ Vaccines. 2024. PMID: 39478007 Free PMC article. Review.
-
Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.Mol Ther. 2017 May 3;25(5):1222-1233. doi: 10.1016/j.ymthe.2017.02.018. Epub 2017 Mar 23. Mol Ther. 2017. PMID: 28342639 Free PMC article.
-
A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv.NPJ Vaccines. 2025 Jul 29;10(1):173. doi: 10.1038/s41541-025-01216-8. NPJ Vaccines. 2025. PMID: 40730746 Free PMC article.
-
Transcriptional Profiling of Early and Late Phases of Bovine Tuberculosis.Infect Immun. 2022 Feb 17;90(2):e0031321. doi: 10.1128/IAI.00313-21. Epub 2021 Dec 13. Infect Immun. 2022. PMID: 34898250 Free PMC article.
-
High-frequency vaccine-induced CD8⁺ T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection.Eur J Immunol. 2014 Jun;44(6):1699-709. doi: 10.1002/eji.201344358. Epub 2014 Mar 27. Eur J Immunol. 2014. PMID: 24677089 Free PMC article.
References
-
- Beschin, A., L. Brijs, P. De Baetselier, and C. Cocito. 1991. Mycobacterial proliferation in macrophages is prevented by incubation with lymphocytes activated in vitro with a mycobacterial antigen complex. Eur. J. Immunol. 21:793-797. - PubMed
-
- Bonecini-Almeida, M. G., S. Chitale, I. Boutsikakis, J. Geng, H. Doo, S. He, and J. L. Ho. 1998. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-γ and primed lymphocytes. J. Immunol. 160:4490-4499. - PubMed
-
- Buddle, B. M., G. W. de Lisle, A. Pfeffer, and F. E. Aldwell. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13:1123-1130. - PubMed
-
- Canaday, D. H., C. Ziebold, E. H. Noss, K. A. Chervenak, C. V. Harding, and W. H. Boom. 1999. Activation of human CD8+ TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J. Immunol. 162:372-379. - PubMed
-
- Carpenter, E., L. Fray, and E. Gormley. 1997. Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes. Immunol. Cell Biol. 75:554-560. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
